There are attempts to increase community access to misoprostol in Kenya. However, several factors may hinder such health-seeking behaviour. And to date, there are no documented evidence examining individual-level factors that may influence self-administration of the drug in Uasin Gishu County or any other part of Kenya.
This study examined the socio-demographic characteristics associated with self-induced abortion with misoprostol among women presenting themselves with abortion-related complications in public health facilities in Uasin Gishu County in Kenya.
Material and Methods
From the sample, the study identified women who had induced their pregnancy with misoprostol. The association between self-induced abortion and the socio-demographic variables was then analysed using the Pearson Chi-square test. Significant variables were subjected to regression analysis after controlling for confounding. Odds Ratio (OR) with confidence interval(CI) was used where possible to ascertain the extent of the association.
The prevalence of self-induced abortion with misoprostol in the County was 25.6% (137). Women who had not completed primary school were .292 times more likely to self-induce their pregnancy with misoprostol, (OR, .292; 95% CI = .10, .83; p = 0.021).
Government of Kenya. Constitution of Kenya. Kenya: Government Printer; 2010.
Rowlands S. Abortion pills: under whose control? J Fam Plann Reprod Health Care. 2012;38:117–22.
Rao K, Faúndes A. Access to safe abortion within the limits of the law. Best Pract Res Clin Obstet Gynaecol. 2006;20:421–32.
Marlow HM, Wamugi S, Yegon E, Fetters T, Wanaswa L, Msipa NS. Women’s perceptions about abortion in their communities: Perspectives from western Kenya. Reprod Health Matters. 2014;22(43):149–58.
Harris LH. Stigma and abortion complications in the United States. Obstet Gynecol. 2012;120:1472–4.
Chong YS, Su LL, Arulkumaran S. Misoprostol: a quarter century of use, abuse, and creative misuse. Obstet Gynecol Surv. 2004;59(2):128–40.
Coeytaux F, Hessini L, Ejano N, Obbuyi A, Oguttu M, Osur J, et al. Facilitating women’s access to misoprostol through community-based advocacy in Kenya and Tanzania. Int J Gynecol Obstet. 2014 Apr 1;125(1):53–5.
Osur J, Baird TL, Levandowski BA, Jackson E, Murokora D. Implementation of misoprostol for postabortion care in Kenya and Uganda: A qualitative evaluation. Glob Health Action. 2013;6(1):1–12.
Bello FA, Fawole B, Oluborode B, Awowole I, Irinyenikan T, Awonuga D, et al. Trends in misoprostol use and abortion complications: A cross-sectional study from nine referral hospitals in Nigeria. PLoS ONE [Internet]. 2018 Dec 31 [cited 2020 Sep 13];13(12). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312220/
Ministry of Health. Kenya Essential Medicines List 2019 [Internet]. Government of Kenya; 2019. Available from: https://www.health.go.ke/wp-content/uploads/2020/03/Kenya-Essential-Medicines-List-2019.pdf
Damalie FJMK, Dassah ET, Morhe ESK, Nakua EK, Tagbor HK, Opare-Addo HS. Severe morbidities associated with induced abortions among misoprostol users and non-users in a tertiary public hospital in Ghana. BMC Womens Health. 2014;14(90):1–8.
Ministry of Health. Standards and guidelines for reducing morbidity and mortality from unsafe abortion in Kenya. Government of Kenya; 2012.
Gebreselassie H, Gallo MF, Monyo A, Johnson BR. The magnitude of abortion complications in Kenya. Int J Obstet Gynaecol. 2005;112(9):1229–35.
Ziraba AK, Izugbara C, Levandowski BA, Gebreselassie H, Mutua M, Mohamed SF, et al. Unsafe abortion in Kenya: a cross-sectional study of abortion complication severity and associated factors. BMC Pregnancy Childbirth. 2015;15(34):1–11.
Government of Kenya. Penal Code [Internet]. Cap 63. Sect. 153 2009. Available from: http://kenyalaw.org:8181/exist/kenyalex/actview.xql?actid=CAP.%2063
Government of Kenya. The Constitution of Kenya [Internet]. Sect. 26(IV) 2010. Available from: http://kenyalaw.org/kl/index.php?id=398
Ushie BA, Juma K, Kimemia G, Ouedraogo R, Bangha M, Mutua M. Community perception of abortion, women who abort and abortifacients in Kisumu and Nairobi counties, Kenya. PLOS ONE. 2019 Dec 12;14(12):e0226120.
Gitonga C, Jennrich L. The State of the Health Referral System in Kenya: Results from a Baseline Study on the Functionality of the Health Referral System in Eight Counties. 2013 Oct p. 1–47.
Jones RK. How commonly do US abortion patients report attempts to self-induce? Am J Obstet Gynecol. 2011;204(1):23.e1-4.
Speer L. Misoprostol Alone is Associated with High Rate of Successful First-Trimester Abortion. Am Fam Physician. 2019 Jul 15;100(2):119–119.
Oguoko K. Misoprostol: The abortion or life saving pill? Standard Digital. 2012 Dec;
Singh S, Bankole A, M. Moore A, M. Mutua M, Izugbara C, Kimani E, et al. Incidence and Complications of Unsafe Abortion in Kenya [Internet]. Guttmacher Institute. 2016 [cited 2020 Oct 11]. Available from: https://www.guttmacher.org/report/incidence-and-complications-unsafe-abortion-kenya
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Ogolla et al.